Prof. Nail Suat Ünver is a Professor of Nephrology with a distinguished academic and clinical background. He earned his professorship from Istanbul Aydın University in 2015 and currently practices with Acibadem Health Group (since 2022). His work focuses on kidney disease and transplantation, supported by active involvement in national and international professional organizations. He is a member of the Turkish Society of Nephrology (including the Istanbul Branch), the Coordination Association of Organ Transplant Organizations of Turkey, the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), and the Society for Transplantation Immunology and Genetics.
Education
- 2015 Istanbul Aydin University / Professor
- 2007 GATA Faculty of Medicine / Associate Professor
- 2002 Gulhane Military Medical Academy Nephrology
- 1998 Gulhane Military Medical Academy Internal Medicine
- 1991 Gulhane Military Medical Academy Faculty of Medicine
Experience
- 2022 Acibadem Health Group
- 2021 – 2022 Liv Hospital Health Group
- 2011 – 2021 Central Hospital, Erdem Hospital, Medicana Health Group
- 2011 ÇAPA Faculty of Medicine, Division of Nephrology, Transplantation Unit
- 2008 – 2011 GATA Haydarpaşa Training Hospital Nephrology Clinic (Associate Professor)
- 2007 – 2008 Kyrenia Military Hospital Chief Physician (Specialist)
- 2002 – 2007 GATA Haydarpaşa Training Hospital (Nephrology Specialist)
- 2002 Marmara University Department of Nephrology
- 1998 – 2000 Foça/Izmir (Internal Medicine Specialist)
- 1992 – 1994 Chief Medical Officer of Gölcük Garrison Infirmary (General Practitioner)
- 1991 – 1992 GATA Medical Faculty Hospital (Medical Intern)
Memberships
- Turkish Society of Nephrology Istanbul Branch
- Coordination Association of Organ Transplant Organizations of Turkey
- European Society of Nephrology (ERA-EDTA)
- Society for Transplantation Immunology and Genetics
- Turkish Society of Nephrology
Publications
- Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine
Clinical Kidney Journal,2021 doi.10.1093/ckj/sfab155 Unver S., Haholu A, Yildirim S. - Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Ren Fail. 2015 Jun 1:1-6. Unver S, Kavlak E, Gümüsel H.K, Celikbilek F, Esertas K, Müftüoglu T, Kirilmaz A. - Objective analysis of voice changes in a hemodialysis session and its correlation with ultrafiltration.
Ren Fail. 2014 Dec 2:1-5. Unver S, Hardal U, Esertas K, Sezen A, Celikbilek F, Altundag A. - Cutaneous Kaposi’s sarcoma following immunosuppressive therapy for membranoproliferative glomerulonephritis.
Clinical Nephrology 2009 72(5): 420-1 Atasoyu EM, Bilgi O, Kinalp C, Karagoz B, Haholu A, Unver S, Evrenkaya TR. - A Case of Peritonitis Resistant to Culture-Positive Treatment nephropathy
Clinical Nephrology 2009; 71(1): 100-102. - Oxidative stress potentials of different synthetic hemodialysis membranes
Dialysis & Transplantation 2008; 37(10): 397+. Unver S, Ipcioglu OM, Kinalp C, Ozcan O, Atasoyu EM, Evrenkaya TR - A rare complication of idiopathic membranous nephropathy : crescentic transformation.
Renal Failure 2008; 30(5): 573-575. Unver S, Haholu A, Atasoyu EM, Karatas M, Akcan R, Evrenkaya TR - The influence of the amount of ultrafiltration in chronic hemodialysis on P wave dispersion.
Ren Fail. 2007;29(2):207-12 Unver S, Ozmen N, Aparci M, Atasoyu EM, Evrenkaya TR. - Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial mediterranean fever.
Ren Fail. 2007 Jan;29 (1):73-77. Nadir H, Unver S, Ozel AM, Yazgan Y, Gultepe M, Evrenkaya TR, Demirturk L, Gurbuz AK. - What changes occur by only increasing blood flow rate in haemodialysis?
International Review Of The Armed Forces Medical Services 2007. 80(3): 144-146. Unver S, Atasoyu EM, Evrenkaya TR, Tulbek MY
